QMS Documents and Production Inspection in Russian Device Registration

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Russia includes production inspection among the grounds for conformity assessment in registration, operating in parallel with quality management system certification. The inspection addresses the ability to realise a specific registration unit under the specific production conditions, while the QMS certificate is an organisational-level demonstration of the management system. For QMS matters the preferred basis is GOST ISO 13485-2017, the identical adoption of ISO 13485:2016, and on the Union path there is a separate decision on QMS requirements. Manufacturers should understand the two instruments as answering different questions and prepare evidence for both.

The practical stakes are high because inspection information is a continuing obligation, not a one-time event. A registration certificate covers the site that was inspected, and the failure to keep inspection arrangements documented and updated can lead to suspension and ultimately revocation of the certificate. At the same time, a QMS evaluation covering design and development opens a simplified change track for low-risk devices, which makes the QMS investment a source of ongoing regulatory flexibility rather than a pure compliance cost.

The distinction also shapes who does what inside the project. The QMS certificate is typically obtained through a certification body on the manufacturer’s own initiative, while the production inspection is arranged within the registration procedure against the specific registration unit. Preparing for both with one shared evidence base, consisting of the technical documentation, the process descriptions and the records of critical steps, avoids duplication of effort. The same set of documents that convinces a certification body that the system is sound also gives the inspector the entry point for verifying that the specific device is reproducibly made at the site.

2. Legal basis

The instruments governing production inspection and QMS requirements are summarised below.

RegulationNumberDateProvisions
Government Resolution of the Russian Federation on the State Registration Rules for Medical DevicesGovernment Resolution of the Russian Federation No. 1684November 30, 2024p. 5 (production inspection as a registration ground), item “zh” of p. 137 (consequences of missing inspection information)
GOST ISO 13485-2017National standardIn forceQuality management system for medical devices
Decision of the Eurasian Economic Commission on QMS requirements (aligned with ISO 13485)EEC Decision No. 106—QMS requirements on the Union path
GOST ISO 14971National standardIn forceRisk management

Note: the date and provision numbers of EEC Decision No. 106 were not obtained from the official text at the time of writing; this article mentions the decision only to flag its existence on the Union path.

3. Expert insights

Insight 1: the inspection target is this product in this factory. A QMS certificate only proves that a management system exists. The inspection verifies whether the technical documentation of the specific registration unit, the critical processes, the inspection records and traceability are actually implemented at the given site. Multi-site and contract manufacturing situations demand particular care: the registration certificate covers only the address that was inspected. A sponsor operating two plants must either register against the inspected address or plan the inspections so that each production address is covered as intended, and the product shipped from an unregistered address is, from the regulatory standpoint, a different case entirely.

Insight 2: inspection information is a continuing obligation. Item “zh” of p. 137 of Resolution No. 1684 lists the absence of information on inspection arrangements or the failure to update documents as required among the grounds for suspension, and a suspension of 180 working days leads into revocation. Deadlines of this length span many calendar months, so reminder systems must convert working days into calendar dates before alerts are set. Companies that track this obligation in calendar terms regularly discover the problem too late; the fix is a compliance register that natively works in working days.

Insight 3: some changes can take the simplified track. Class 1 devices and non-sterile Class 2a devices whose QMS evaluation covered the design and development processes may, within the validity period of the inspection report, make partial changes under item “b” of p. 111 without expert review. This is the direct return on the QMS investment: the same system that satisfies the inspection requirement also buys a faster change path for low-risk devices. Sponsors of such products should deliberately scope the QMS evaluation to include design and development to preserve this option.

For contract manufacturers the consequences reach into the commercial contract itself. The registration holder needs the right to present the site for inspection, access to batch records and the ability to update inspection information, and these rights should be secured in the supply or development agreement before the registration application is filed. A manufacturer who cannot produce the inspection-related documents on demand exposes the certificate to suspension under item “zh” of p. 137, regardless of how good the product is. Aligning the regulatory duties with the contractual duties is therefore part of registration planning, not an afterthought to be settled when the inspector’s letter arrives.

4. Practical recommendations

  1. For foreign factories, run a mock inspection in advance covering the four essential blocks: technical documentation, batch records, inspection capability and complaint handling.
  2. For multi-site manufacturing, plan registration address by address and do not expect one certificate to cover all production sites.
  3. Include the validity periods of the QMS evaluation and the inspection report in the compliance register, and schedule re-evaluations before expiry to keep the eligibility for the simplified change track.
  4. Align the addresses stated in the QMS certificate and the inspection report with the registration file, so that reviewers find one consistent site picture.
  5. Update inspection information promptly whenever production arrangements change, treating this as a standing obligation with a named owner.

5. Verification checklist

  • □ The production address is included in the registration file and matches the QMS certificate and inspection report addresses
  • □ Initial and periodic production inspections have been scheduled and inspection information submitted or updated
  • □ The QMS evaluation scope covers the design and development processes (where the simplified change track is intended)
  • □ Inspection and QMS validity periods are in the register with reminders set
  • □ Multi-site capacity has a registration plan defined address by address

Regulatory information verified as of October 29, 2026.

GRZAN assists manufacturers with production readiness for the Russian market, from mock inspections and QMS documentation aligned with GOST ISO 13485-2017 to the maintenance of inspection information and the preservation of simplified change eligibility for low-risk devices. Our consultants keep your sites, certificates and registration file in one consistent picture. For support with production inspection and QMS matters in Russia, contact us at info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail